These are animal vaccines. None of them is a vaccine for people. Every product on these pages is authorised for the animal species named in its row, by the UK Veterinary Medicines Directorate. A product licensed for cattle or poultry says nothing about whether protection exists for a person, and several of these viruses do not infect people at all.
Looking for human vaccines? Use the main Virus Navigator.
At a glance
| Abbreviation | CDV |
|---|---|
| ICTV species | Morbillivirus canis |
| Family | Paramyxoviridae |
| Baltimore class | V — (−)ssRNA |
| Human infection | Not known to infect humans |
Also called: Canine morbillivirus; Morbillivirus canis
Riboviria › Negarnaviricota › Monjiviricetes › Mononegavirales › Paramyxoviridae › Morbillivirus
What it is
Taxonomy copied from ICTV MSL41.v1 / VMR_MSL41.v1.20260729.xlsx. These ranks are not hand-edited; a correction means re-running the fetch against a newer release.
| Realm | Riboviria |
|---|---|
| Kingdom | Orthornavirae |
| Phylum | Negarnaviricota |
| Class | Monjiviricetes |
| Order | Mononegavirales |
| Family | Paramyxoviridae |
| Subfamily | Orthoparamyxovirinae |
| Genus | Morbillivirus |
| ICTV identifier | ICTV19760282 |
| NCBI taxon | 3052342 |
| Exemplar isolate | AF014953 |
Host evidence
- dog: 658 GenBank records
Counts of nucleotide records annotated with that host. Evidence of provenance, not a statement of host range.
Where it occurs
Not searched yet. No country-level occurrence data has been curated for this virus. The WHO reported-case data on this site covers a limited set of diseases; a virus outside it gets no map rather than an empty one.
What it does
Not searched yet. Burden, severity and transmissibility figures have not been curated for this virus yet. When they are, each will carry the exact sentence from its source.
Vaccines
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| Canigen DHP Lyophilisate and Solvent for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A006702 (VM 06376/4114); active substance 'Canine distempe |
| Canigen DHPPi Lyophilisate for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A003500 (VM 06376/4107); active substance 'Canine distempe |
| Canixin DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs | Virbac | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A011494 (VM 05653/3067); active substance 'Canine distempe |
| Canixin DHPPi/L | VIRBAC | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011495 (VM 05653/3023); active substance 'Canine distempe |
| CANIXIN DHPPi/L Lyophilisate and Suspension for Suspension for Injection for Dogs | Virbac | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A008317 (VM 05653/5054); active substance 'Canine distempe |
| Eurican DAP Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Animal Health UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A009494 (VM 08327/5023); active substance 'Canine distempe |
| Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection | Boehringer Ingelheim Animal Health UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A009495 (VM 08327/5024); active substance 'Canine distempe |
| Eurican DHPPi Lyophilisate for Suspension for Injection | Boehringer Ingelheim Animal Health UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A002697 (VM 08327/5053); active substance 'Canine distempe |
| Musteligen D Lyophilisate and Solvent for Suspension for Injection for Ferrets | Virbac | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A010431 (VM 05653/4227); active substance 'Canine distempe |
| Nobivac DHP | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A012179 (VM 06376/3036); active substance 'Canine distempe |
| Nobivac DHPPi, Lyophilisate for Suspension for Injection for Dogs | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A001797 (VM 06376/4104); active substance 'Canine distempe |
| Nobivac DP PLUS Lyophilisate and Solvent for Suspension for Injection for Puppies | Intervet International B.V. | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A011079 (VM EU/2/20/265/001-002); active substance 'Canine |
| Vanguard 7 | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A002548 (VM 42058/5178); active substance 'Canine distempe |
| Versican Plus DHPPi Lyophilisate and Solvent for Suspension for Injection for Dogs | Zoetis UK Limited | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A008842 (VM 42058/5082); active substance 'Canine distempe |
| Versican plus DHPPi/L4 | Zoetis Belgium | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A011245 (VM EU/2/14/164/001-002); active substance 'Canine |
| Versican Plus DHPPi/L4 Lyophilisate and Suspension for Suspension for Injection for Dogs | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A008812 (VM 42058/5083); active substance 'Canine distempe |
| Versican Plus DHPPi/L4R Lyophilisate and Suspension for Suspension for Injection for Dogs | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A008768 (VM 42058/5081); active substance 'Canine distempe |
Antivirals
Not searched yet. No US-approved antiviral for this virus was found in the openFDA drug label endpoint. Only US labels were searched, and only drugs the FDA classes as antivirals.
Antibodies and immune globulins
Not searched yet. No US-approved antiviral antibody for this virus was found in the openFDA drug label endpoint.
Approval status is not a treatment recommendation. Dosing and eligibility are on the label and in national guidelines. This page does not give medical advice and does not render dosing. A development stage is not a measure of how well something works.